NLM Logo

nilotinib MeSH Supplementary Concept Data 2022


MeSH Supplementary
nilotinib
Unique ID
C498826
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C498826
Entry Term(s)
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
AMN 107
AMN-107
AMN107
Tasigna
benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride (1:1)
benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate
benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (1:1:2)
benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (1:2:2)
benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (2:2:3)
nilotinib dihydrochloride dihydrate
nilotinib hydrochloride
nilotinib hydrochloride anhydrous
nilotinib hydrochloride dihydrate
nilotinib hydrochloride hydrate
nilotinib hydrochloride monohydrate
nilotinib hydrochloride sesquihydrate
Registry Number
F41401512X
Related Numbers
5JHU0N1R6K
FQV3UFL546
K37N7BYX3X
WM15I3PF3G
Y37S7HA3BC
Heading Mapped to
*Pyrimidines
Frequency
1374
Note
antineoplastic agent
Source
Cancer Cell 2005 Feb;7(2):117-9
Indexing Information
Protein-Tyrosine Kinases
Date of Entry
2005/04/06
Revision Date
2022/01/13
nilotinib Preferred
nilotinib hydrochloride dihydrate Narrower
nilotinib hydrochloride anhydrous Narrower
nilotinib hydrochloride hydrate Narrower
nilotinib hydrochloride sesquihydrate Narrower
nilotinib dihydrochloride dihydrate Narrower
AMN107 Narrower
page delivered in 0.007s